{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"The median number of days to PMN engraftment criteria was PMN counts ≥ 0.5\\*10\\^9/L for 3 consecutive days or ≥ 1.0\\*10\\^9/L for 1 day. Time to engraftment corresponded to the first day that criteria were met.\n\nThis study was terminated early and analysis was not done.","groups":[{"description":"Mobilization with Granulocyte Colony Stimulating Factor (G-CSF) (10 µg/kg once a day) for 5 days. Patients received once daily plerixafor treatment (240 mg/kg) in the evening (10 to 11 hours prior to apheresis) for up to 3 days if peripheral blood CD34+ cell counts on Day 5 met the entry criteria. Morning doses of G-CSF (10 µg/kg) continued throughout apheresis.","id":"OG000","title":"All Patients"}],"populationDescription":"This study was terminated early and analysis was not done.","reportingStatus":"POSTED","timeFrame":"2 months","title":"Number of Days to Polymorphonuclear Leukocyte (PMN) Engraftment","type":"SECONDARY"}